Stay updated on DeRIVE for Newly Diagnosed Myeloma Clinical Trial
Sign up to get notified when there's something new on the DeRIVE for Newly Diagnosed Myeloma Clinical Trial page.

Latest updates to the DeRIVE for Newly Diagnosed Myeloma Clinical Trial page
- Check4 days agoChange DetectedA banner announces updates to NIH websites and says that some content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check11 days agoChange DetectedThe site revision label in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check18 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record content, replacing the study details with a generic error page.SummaryDifference23%

- Check60 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6 on the page, signaling a refreshed version of the content. This update reflects a new release or revision entry but does not change the substantive study information presented.SummaryDifference0.0%

- Check81 days agoChange DetectedThe study record's metadata was updated to reflect the latest revision (v3.6.5), the last verified status (Unknown), and the attribution to Emory University and Ajay Nooka as of 2024-06.SummaryDifference0.5%

Stay in the know with updates to DeRIVE for Newly Diagnosed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DeRIVE for Newly Diagnosed Myeloma Clinical Trial page.